HFA Premium Access

Maximal functional capacity response to physical therapies according to ferrokinetics in heart failure with preserved ejection fraction. A substudy of the training-hf trial

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Patricia Palau Sampio

Valencia University Clinical Hospital, Valencia (Spain)
1 presentation
0 follower

4 more presentations in this session

A ventricular conduction delay phenotype and its outcome in heart failure with preserved ejection fraction

Speaker: Ms A. Achten (Maastricht, NL)

Thumbnail

Invasive validation of H2FPEF score for diagnosis of heart failure with preserved ejection fraction (HFpEF)

Speaker: Doctor M. Podolec (Prague, CZ)

Thumbnail

Retinal neurovascular changes in heart failure with preserved ejection fraction: an optical coherence tomography angiography pilot study

Speaker: Mr J. Weerts (Maastricht, NL)

Thumbnail

Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

Speaker: Doctor J. Ostrominski (Boston, US)

Thumbnail

Access the full session

Heart failure with preserved ejection fraction (HFpEF) 3

Speakers: Doctor P. Palau Sampio, Ms A. Achten, Doctor M. Podolec, Mr J. Weerts, Doctor J. Ostrominski
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb